Advances in the Study of Invasive Non-mucinous Adenocarcinoma with Different Pathological Subtypes
Lung cancer is the leading cause of cancer death in the world today, and adenocarcinoma is the most common histopathological type of lung cancer. In May 2021, World Health Organization (WHO) released the 5th edition of the WHO classification of thoracic tumors, which classifies invasive non-mucinous...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-01-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.51 |
| _version_ | 1797905445613993984 |
|---|---|
| author | Ruke TANG Lina BI Bingquan XIANG Lianhua YE Ying CHEN Guangjian LI Guangqiang ZHAO Yunchao HUANG |
| author_facet | Ruke TANG Lina BI Bingquan XIANG Lianhua YE Ying CHEN Guangjian LI Guangqiang ZHAO Yunchao HUANG |
| author_sort | Ruke TANG |
| collection | DOAJ |
| description | Lung cancer is the leading cause of cancer death in the world today, and adenocarcinoma is the most common histopathological type of lung cancer. In May 2021, World Health Organization (WHO) released the 5th edition of the WHO classification of thoracic tumors, which classifies invasive non-mucinous adenocarcinoma (INMA) into lepidic adenocarcinoma, acinar adenocarcinoma, papillary adenocarcinoma, solid adenocarcinoma, and micropapillary adenocarcinoma based on its histological characteristics. These five pathological subtypes differ in clinical features, treatment and prognosis. A complete understanding of the characteristics of these subtypes is essential for the clinical diagnosis, treatment options, and prognosis predictions of patients with lung adenocarcinoma, including recurrence and progression. This article will review the grading system, morphology, imaging prediction, lymph node metastasis, surgery, chemotherapy, targeted therapy and immunotherapy of different pathological subtypes of INMA. |
| first_indexed | 2024-04-10T10:05:25Z |
| format | Article |
| id | doaj.art-2c83a19f38744db0b423b8cd83824423 |
| institution | Directory Open Access Journal |
| issn | 1009-3419 1999-6187 |
| language | zho |
| last_indexed | 2024-04-10T10:05:25Z |
| publishDate | 2023-01-01 |
| publisher | Chinese Anti-Cancer Association; Chinese Antituberculosis Association |
| record_format | Article |
| series | Chinese Journal of Lung Cancer |
| spelling | doaj.art-2c83a19f38744db0b423b8cd838244232023-02-16T00:55:34ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872023-01-01261223010.3779/j.issn.1009-3419.2022.102.51Advances in the Study of Invasive Non-mucinous Adenocarcinoma
with Different Pathological SubtypesRuke TANG0Lina BI1Bingquan XIANG2Lianhua YE3Ying CHEN4Guangjian LI5Guangqiang ZHAO6Yunchao HUANG7Department of Thoracic Surgery I, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, ChinaDepartment of Nephrology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, ChinaDepartment of Intensive Care Unit, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, ChinaDepartment of Thoracic Surgery I, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, ChinaDepartment of Thoracic Surgery I, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, ChinaDepartment of Thoracic Surgery I, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, ChinaDepartment of Thoracic Surgery I, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, ChinaDepartment of Thoracic Surgery I, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, ChinaLung cancer is the leading cause of cancer death in the world today, and adenocarcinoma is the most common histopathological type of lung cancer. In May 2021, World Health Organization (WHO) released the 5th edition of the WHO classification of thoracic tumors, which classifies invasive non-mucinous adenocarcinoma (INMA) into lepidic adenocarcinoma, acinar adenocarcinoma, papillary adenocarcinoma, solid adenocarcinoma, and micropapillary adenocarcinoma based on its histological characteristics. These five pathological subtypes differ in clinical features, treatment and prognosis. A complete understanding of the characteristics of these subtypes is essential for the clinical diagnosis, treatment options, and prognosis predictions of patients with lung adenocarcinoma, including recurrence and progression. This article will review the grading system, morphology, imaging prediction, lymph node metastasis, surgery, chemotherapy, targeted therapy and immunotherapy of different pathological subtypes of INMA.http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.51lung neoplasmsinvasive adenocarcinomainvasive non-mucinous adenocarcinomapathological subtypes |
| spellingShingle | Ruke TANG Lina BI Bingquan XIANG Lianhua YE Ying CHEN Guangjian LI Guangqiang ZHAO Yunchao HUANG Advances in the Study of Invasive Non-mucinous Adenocarcinoma with Different Pathological Subtypes Chinese Journal of Lung Cancer lung neoplasms invasive adenocarcinoma invasive non-mucinous adenocarcinoma pathological subtypes |
| title | Advances in the Study of Invasive Non-mucinous Adenocarcinoma
with Different Pathological Subtypes |
| title_full | Advances in the Study of Invasive Non-mucinous Adenocarcinoma
with Different Pathological Subtypes |
| title_fullStr | Advances in the Study of Invasive Non-mucinous Adenocarcinoma
with Different Pathological Subtypes |
| title_full_unstemmed | Advances in the Study of Invasive Non-mucinous Adenocarcinoma
with Different Pathological Subtypes |
| title_short | Advances in the Study of Invasive Non-mucinous Adenocarcinoma
with Different Pathological Subtypes |
| title_sort | advances in the study of invasive non mucinous adenocarcinoma
with different pathological subtypes |
| topic | lung neoplasms invasive adenocarcinoma invasive non-mucinous adenocarcinoma pathological subtypes |
| url | http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.51 |
| work_keys_str_mv | AT ruketang advancesinthestudyofinvasivenonmucinousadenocarcinomawithdifferentpathologicalsubtypes AT linabi advancesinthestudyofinvasivenonmucinousadenocarcinomawithdifferentpathologicalsubtypes AT bingquanxiang advancesinthestudyofinvasivenonmucinousadenocarcinomawithdifferentpathologicalsubtypes AT lianhuaye advancesinthestudyofinvasivenonmucinousadenocarcinomawithdifferentpathologicalsubtypes AT yingchen advancesinthestudyofinvasivenonmucinousadenocarcinomawithdifferentpathologicalsubtypes AT guangjianli advancesinthestudyofinvasivenonmucinousadenocarcinomawithdifferentpathologicalsubtypes AT guangqiangzhao advancesinthestudyofinvasivenonmucinousadenocarcinomawithdifferentpathologicalsubtypes AT yunchaohuang advancesinthestudyofinvasivenonmucinousadenocarcinomawithdifferentpathologicalsubtypes |